BACKGROUND & AIMS: The relative efficacies of licensed antiviral therapies for treatment-naive
chronic hepatitis B (CHB) infection in randomized controlled trials have not been …

Purpose Hepatitis B virus (HBV) reactivation is a potentially fatal complication of chemotherapy
that can be largely prevented with antiviral prophylaxis. It remains unclear whether HBV …

BACKGROUND: The effect of chronic hepatitis B (CHB) infection on health-related quality of
life (HRQoL) and health state utilities has not been well characterized.OBJECTIVE: To …

Cost-effectiveness/cost-utility studies of hepatitis A vaccine were identified via a series of
literature searches (MEDLINE, EMBASE, HSTAR and SSCI). Citations and full-text articles were …

Background: The prevalence of chronic hepatitis B (CHB) infection among the immigrants of
North America ranges from 2 to 15%, among whom 40% develop advanced liver disease. …

BACKGROUND: The prevalence of chronic hepatitis B (CHB) infection among immigrants to
North America ranges from 2% to 15%, 40% of whom develop advanced liver disease. …

Background Invasive meningococcal disease (IMD) is a serious disease with a rapid onset,
high mortality rate, and risk of long-term complications. Numerous reports in the literature …

PURPOSE: Percutaneous image-guided techniques are associated with less tissue trauma
and morbidity than open surgical techniques. Interventional radiology has received …

… Hai Nguyen, William Wong and Gloria Woo contributed to the concept and design of the
analysis; collected, analyzed and interpreted the data; and revised the manuscript. Harindra …

Background Cardiovascular disease (CVD) is a leading cause of death in Canada and is a
priority area for medical research. The research funding landscape in Canada has changed …